|
CASK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.42790010318572E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84691999999265E-05 |
| Normal-vs-Stage2 |
5.142200E-02 |
| Normal-vs-Stage3 |
1.449860E-02 |
| Normal-vs-Stage4 |
1.518590E-01 |
| Stage1-vs-Stage2 |
9.745200E-01 |
| Stage1-vs-Stage3 |
2.912800E-01 |
| Stage1-vs-Stage4 |
6.441400E-01 |
| Stage2-vs-Stage3 |
3.805800E-01 |
| Stage2-vs-Stage4 |
6.296600E-01 |
| Stage3-vs-Stage4 |
1.746590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11680000025594E-07 |
| Normal-vs-AfricanAmerican |
2.751900E-04 |
| Normal-vs-Asian |
6.928200E-01 |
| Caucasian-vs-AfricanAmerican |
9.176200E-01 |
| Caucasian-vs-Asian |
4.001800E-01 |
| AfricanAmerican-vs-Asian |
3.099600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.0864999999981E-05 |
| Normal-vs-Female |
8.0169000327146E-09 |
| Male-vs-Female |
5.002200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.177700E-03 |
| Normal-vs-Extreme_Weight |
1.301140E-03 |
| Normal-vs-Obese |
3.985300E-04 |
| Normal-vs-Extreme_Obese |
3.080600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.434000E-01 |
| Normal_Weight-vs-Obese |
6.953600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.879400E-01 |
| Extreme_Weight-vs-Obese |
2.148200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.241400E-01 |
| Obese-vs-Extreme_Obese |
3.896800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.361910E-02 |
| Normal-vs-Age(41-60Yrs) |
3.95540000752703E-09 |
| Normal-vs-Age(61-80Yrs) |
3.504300E-03 |
| Normal-vs-Age(81-100Yrs) |
7.278400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.084400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.643600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.546100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.970500E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.797600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.695000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.91799958932415E-10 |
| Normal-VS-Type2 PRCC |
3.293600E-01 |
| Normal-VS-KIRP CIMP |
3.068300E-02 |
| Normal-VS-Unclassified PRCC |
3.079200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.364260E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.730170E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.357800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.838500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.480300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.603700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.143600E-02 |
| Normal-vs-N1 |
8.341200E-03 |
| Normal-vs-N2 |
5.260300E-02 |
| N0-vs-N1 |
8.464100E-02 |
| N0-vs-N2 |
3.395000E-01 |
| N1-vs-N2 |
8.705200E-01 |
|
|
